Literature DB >> 26215693

Prostate cancer: Intrapatient heterogeneity in prostate cancer.

Himisha Beltran1, Francesca Demichelis2.   

Abstract

Entities:  

Mesh:

Year:  2015        PMID: 26215693     DOI: 10.1038/nrurol.2015.182

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN: 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  10 in total

1.  Spatial genomic heterogeneity within localized, multifocal prostate cancer.

Authors:  Paul C Boutros; Michael Fraser; Nicholas J Harding; Richard de Borja; Dominique Trudel; Emilie Lalonde; Alice Meng; Pablo H Hennings-Yeomans; Andrew McPherson; Veronica Y Sabelnykova; Amin Zia; Natalie S Fox; Julie Livingstone; Yu-Jia Shiah; Jianxin Wang; Timothy A Beck; Cherry L Have; Taryne Chong; Michelle Sam; Jeremy Johns; Lee Timms; Nicholas Buchner; Ada Wong; John D Watson; Trent T Simmons; Christine P'ng; Gaetano Zafarana; Francis Nguyen; Xuemei Luo; Kenneth C Chu; Stephenie D Prokopec; Jenna Sykes; Alan Dal Pra; Alejandro Berlin; Andrew Brown; Michelle A Chan-Seng-Yue; Fouad Yousif; Robert E Denroche; Lauren C Chong; Gregory M Chen; Esther Jung; Clement Fung; Maud H W Starmans; Hanbo Chen; Shaylan K Govind; James Hawley; Alister D'Costa; Melania Pintilie; Daryl Waggott; Faraz Hach; Philippe Lambin; Lakshmi B Muthuswamy; Colin Cooper; Rosalind Eeles; David Neal; Bernard Tetu; Cenk Sahinalp; Lincoln D Stein; Neil Fleshner; Sohrab P Shah; Colin C Collins; Thomas J Hudson; John D McPherson; Theodorus van der Kwast; Robert G Bristow
Journal:  Nat Genet       Date:  2015-05-25       Impact factor: 38.330

2.  Molecular characterization of neuroendocrine prostate cancer and identification of new drug targets.

Authors:  Himisha Beltran; David S Rickman; Kyung Park; Sung Suk Chae; Andrea Sboner; Theresa Y MacDonald; Yuwei Wang; Karen L Sheikh; Stéphane Terry; Scott T Tagawa; Rajiv Dhir; Joel B Nelson; Alexandre de la Taille; Yves Allory; Mark B Gerstein; Sven Perner; Kenneth J Pienta; Arul M Chinnaiyan; Yuzhuo Wang; Colin C Collins; Martin E Gleave; Francesca Demichelis; David M Nanus; Mark A Rubin
Journal:  Cancer Discov       Date:  2011-11       Impact factor: 39.397

3.  Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer.

Authors:  Christopher E Barbieri; Sylvan C Baca; Michael S Lawrence; Francesca Demichelis; Mirjam Blattner; Jean-Philippe Theurillat; Thomas A White; Petar Stojanov; Eliezer Van Allen; Nicolas Stransky; Elizabeth Nickerson; Sung-Suk Chae; Gunther Boysen; Daniel Auclair; Robert C Onofrio; Kyung Park; Naoki Kitabayashi; Theresa Y MacDonald; Karen Sheikh; Terry Vuong; Candace Guiducci; Kristian Cibulskis; Andrey Sivachenko; Scott L Carter; Gordon Saksena; Douglas Voet; Wasay M Hussain; Alex H Ramos; Wendy Winckler; Michelle C Redman; Kristin Ardlie; Ashutosh K Tewari; Juan Miguel Mosquera; Niels Rupp; Peter J Wild; Holger Moch; Colm Morrissey; Peter S Nelson; Philip W Kantoff; Stacey B Gabriel; Todd R Golub; Matthew Meyerson; Eric S Lander; Gad Getz; Mark A Rubin; Levi A Garraway
Journal:  Nat Genet       Date:  2012-05-20       Impact factor: 38.330

Review 4.  MYC oncogenes and human neoplastic disease.

Authors:  C E Nesbit; J M Tersak; E V Prochownik
Journal:  Oncogene       Date:  1999-05-13       Impact factor: 9.867

5.  DNA methylation alterations exhibit intraindividual stability and interindividual heterogeneity in prostate cancer metastases.

Authors:  Martin J Aryee; Wennuan Liu; Julia C Engelmann; Philipp Nuhn; Meltem Gurel; Michael C Haffner; David Esopi; Rafael A Irizarry; Robert H Getzenberg; William G Nelson; Jun Luo; Jianfeng Xu; William B Isaacs; G Steven Bova; Srinivasan Yegnasubramanian
Journal:  Sci Transl Med       Date:  2013-01-23       Impact factor: 17.956

6.  Tracking the clonal origin of lethal prostate cancer.

Authors:  Michael C Haffner; Timothy Mosbruger; David M Esopi; Helen Fedor; Christopher M Heaphy; David A Walker; Nkosi Adejola; Meltem Gürel; Jessica Hicks; Alan K Meeker; Marc K Halushka; Jonathan W Simons; William B Isaacs; Angelo M De Marzo; William G Nelson; Srinivasan Yegnasubramanian
Journal:  J Clin Invest       Date:  2013-10-25       Impact factor: 14.808

7.  Integrative clinical genomics of advanced prostate cancer.

Authors:  Dan Robinson; Eliezer M Van Allen; Yi-Mi Wu; Nikolaus Schultz; Robert J Lonigro; Juan-Miguel Mosquera; Bruce Montgomery; Mary-Ellen Taplin; Colin C Pritchard; Gerhardt Attard; Himisha Beltran; Wassim Abida; Robert K Bradley; Jake Vinson; Xuhong Cao; Pankaj Vats; Lakshmi P Kunju; Maha Hussain; Felix Y Feng; Scott A Tomlins; Kathleen A Cooney; David C Smith; Christine Brennan; Javed Siddiqui; Rohit Mehra; Yu Chen; Dana E Rathkopf; Michael J Morris; Stephen B Solomon; Jeremy C Durack; Victor E Reuter; Anuradha Gopalan; Jianjiong Gao; Massimo Loda; Rosina T Lis; Michaela Bowden; Stephen P Balk; Glenn Gaviola; Carrie Sougnez; Manaswi Gupta; Evan Y Yu; Elahe A Mostaghel; Heather H Cheng; Hyojeong Mulcahy; Lawrence D True; Stephen R Plymate; Heidi Dvinge; Roberta Ferraldeschi; Penny Flohr; Susana Miranda; Zafeiris Zafeiriou; Nina Tunariu; Joaquin Mateo; Raquel Perez-Lopez; Francesca Demichelis; Brian D Robinson; Marc Schiffman; David M Nanus; Scott T Tagawa; Alexandros Sigaras; Kenneth W Eng; Olivier Elemento; Andrea Sboner; Elisabeth I Heath; Howard I Scher; Kenneth J Pienta; Philip Kantoff; Johann S de Bono; Mark A Rubin; Peter S Nelson; Levi A Garraway; Charles L Sawyers; Arul M Chinnaiyan
Journal:  Cell       Date:  2015-05-21       Impact factor: 41.582

8.  The evolutionary history of lethal metastatic prostate cancer.

Authors:  Christopher Foster; Douglas Easton; Ultan McDermott; David C Wedge; G Steven Bova; Gunes Gundem; Peter Van Loo; Barbara Kremeyer; Ludmil B Alexandrov; Jose M C Tubio; Elli Papaemmanuil; Daniel S Brewer; Heini M L Kallio; Gunilla Högnäs; Matti Annala; Kati Kivinummi; Victoria Goody; Calli Latimer; Sarah O'Meara; Kevin J Dawson; William Isaacs; Michael R Emmert-Buck; Matti Nykter; Zsofia Kote-Jarai; Hayley C Whitaker; David E Neal; Colin S Cooper; Rosalind A Eeles; Tapio Visakorpi; Peter J Campbell
Journal:  Nature       Date:  2015-04-01       Impact factor: 49.962

9.  Analysis of the genetic phylogeny of multifocal prostate cancer identifies multiple independent clonal expansions in neoplastic and morphologically normal prostate tissue.

Authors:  Colin S Cooper; Rosalind Eeles; David C Wedge; Peter Van Loo; Anne Y Warren; Christopher S Foster; Hayley C Whitaker; Ultan McDermott; Daniel S Brewer; David E Neal; Gunes Gundem; Ludmil B Alexandrov; Barbara Kremeyer; Adam Butler; Andrew G Lynch; Niedzica Camacho; Charlie E Massie; Jonathan Kay; Hayley J Luxton; Sandra Edwards; ZSofia Kote-Jarai; Nening Dennis; Sue Merson; Daniel Leongamornlert; Jorge Zamora; Cathy Corbishley; Sarah Thomas; Serena Nik-Zainal; Sarah O'Meara; Lucy Matthews; Jeremy Clark; Rachel Hurst; Richard Mithen; Robert G Bristow; Paul C Boutros; Michael Fraser; Susanna Cooke; Keiran Raine; David Jones; Andrew Menzies; Lucy Stebbings; Jon Hinton; Jon Teague; Stuart McLaren; Laura Mudie; Claire Hardy; Elizabeth Anderson; Olivia Joseph; Victoria Goody; Ben Robinson; Mark Maddison; Stephen Gamble; Christopher Greenman; Dan Berney; Steven Hazell; Naomi Livni; Cyril Fisher; Christopher Ogden; Pardeep Kumar; Alan Thompson; Christopher Woodhouse; David Nicol; Erik Mayer; Tim Dudderidge; Nimish C Shah; Vincent Gnanapragasam; Thierry Voet; Peter Campbell; Andrew Futreal; Douglas Easton; Michael R Stratton
Journal:  Nat Genet       Date:  2015-03-02       Impact factor: 38.330

10.  Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer.

Authors:  Wennuan Liu; Sari Laitinen; Sofia Khan; Mauno Vihinen; Jeanne Kowalski; Guoqiang Yu; Li Chen; Charles M Ewing; Mario A Eisenberger; Michael A Carducci; William G Nelson; Srinivasan Yegnasubramanian; Jun Luo; Yue Wang; Jianfeng Xu; William B Isaacs; Tapio Visakorpi; G Steven Bova
Journal:  Nat Med       Date:  2009-04-12       Impact factor: 53.440

  10 in total
  11 in total

Review 1.  Genomic and phenotypic heterogeneity in prostate cancer.

Authors:  Michael C Haffner; Wilbert Zwart; Martine P Roudier; Lawrence D True; William G Nelson; Jonathan I Epstein; Angelo M De Marzo; Peter S Nelson; Srinivasan Yegnasubramanian
Journal:  Nat Rev Urol       Date:  2020-12-16       Impact factor: 14.432

Review 2.  Overcoming Oncogenic Mediated Tumor Immunity in Prostate Cancer.

Authors:  Geoffrey Bryant; Lin Wang; David J Mulholland
Journal:  Int J Mol Sci       Date:  2017-07-17       Impact factor: 5.923

3.  Combinatorial Ranking of Gene Sets to Predict Disease Relapse: The Retinoic Acid Pathway in Early Prostate Cancer.

Authors:  Hieu T Nim; Milena B Furtado; Mirana Ramialison; Sarah E Boyd
Journal:  Front Oncol       Date:  2017-03-15       Impact factor: 6.244

Review 4.  Live-single-cell phenotypic cancer biomarkers-future role in precision oncology?

Authors:  Grannum R Sant; Kevin B Knopf; David M Albala
Journal:  NPJ Precis Oncol       Date:  2017-06-15

5.  Comprehensive metabolomics analysis of prostate cancer tissue in relation to tumor aggressiveness and TMPRSS2-ERG fusion status.

Authors:  Ilona Dudka; Elin Thysell; Kristina Lundquist; Henrik Antti; Diego Iglesias-Gato; Amilcar Flores-Morales; Anders Bergh; Pernilla Wikström; Gerhard Gröbner
Journal:  BMC Cancer       Date:  2020-05-18       Impact factor: 4.430

6.  A data-driven ultrasound approach discriminates pathological high grade prostate cancer.

Authors:  Jun Akatsuka; Yasushi Numata; Hiromu Morikawa; Tetsuro Sekine; Shigenori Kayama; Hikaru Mikami; Masato Yanagi; Yuki Endo; Hayato Takeda; Yuka Toyama; Ruri Yamaguchi; Go Kimura; Yukihiro Kondo; Yoichiro Yamamoto
Journal:  Sci Rep       Date:  2022-01-17       Impact factor: 4.379

Review 7.  The Role of Epigenetic Change in Therapy-Induced Neuroendocrine Prostate Cancer Lineage Plasticity.

Authors:  William K Storck; Allison M May; Thomas C Westbrook; Zhi Duan; Colm Morrissey; Joel A Yates; Joshi J Alumkal
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-14       Impact factor: 6.055

8.  Defining order and timing of mutations during cancer progression: the TO-DAG probabilistic graphical model.

Authors:  Paola Lecca; Nicola Casiraghi; Francesca Demichelis
Journal:  Front Genet       Date:  2015-10-13       Impact factor: 4.599

9.  Hypoxia on the Expression of Hepatoma Upregulated Protein in Prostate Cancer Cells.

Authors:  Ingrid Espinoza; Marcelo J Sakiyama; Tangeng Ma; Logan Fair; Xinchun Zhou; Mohamed Hassan; Jovanny Zabaleta; Christian R Gomez
Journal:  Front Oncol       Date:  2016-06-15       Impact factor: 6.244

Review 10.  Genetics and biology of prostate cancer.

Authors:  Guocan Wang; Di Zhao; Denise J Spring; Ronald A DePinho
Journal:  Genes Dev       Date:  2018-09-01       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.